Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity
A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1600 participants.
Also called NCT02208765
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 1,600 participants
- Registry
-
NCT02208765
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Unknown status
Technical summary
Registry record NCT02208765. Allocation not applicable; no masking; primary purpose diagnostic. Start 2015-01 (actual); primary completion 2022-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prognostic Value of SPECT-imaging Myocardial Perfusion Heterogeneity
- Acronym
- EVAPERF
- Condition
- Coronary Artery Disease
- Condition
- Coronary Atherosclerosis
- Intervention (Device)
- Stress Single Photon Emission Computed Tomography
- Lead sponsor
- University Hospital, Grenoble
Record details
- Record id
cardio:ct-nct02208765- Content hash
6bf60f7713fc0291f9ee4810d5c5be5a29c9dc78293fc6c719e9708f85c5b2de